Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers Read more
Novartis Cosentyx (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions Read more
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza for the Treatment of AADC Deficiency Read more
Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines Read more
AbbVie Submits New Drug Application to FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson’s Disease Read more
CHMP Recommends Approval of Lilly and Incyte’s OLUMIANT (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA) Read more
PURIFY’22 Takes Chromatography Purification Notches Higher; Industry Rallies Around this Mega Event Read more
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib’s Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine Read more